Andrew Offer - 14 Jul 2021 Form 3 Insider Report for Sight Sciences, Inc. (SGHT)

Role
Director
Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Andrew Offer
Issuer symbol
SGHT
Transactions as of
14 Jul 2021
Net transactions value
$0
Form type
3
Filing time
14 Jul 2021, 20:55:39 UTC
Next filing
19 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SGHT Common Stock 129,310 14 Jul 2021 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SGHT Series C Redeemable Convertible Preferred Stock 14 Jul 2021 Common Stock 3,162 Direct F1
holding SGHT Series A Redeemable Convertible Preferred Stock 14 Jul 2021 Common Stock 2,173,912 See Footnote F1, F2
holding SGHT Series B Redeemable Convertible Preferred Stock 14 Jul 2021 Common Stock 51,840 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The preferred stock is convertible into common stock on a 2 for 1 basis and will automatically convert upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
F2 These shares are held of record by Scientific Health Development II, Ltd. ("SHD II"). SHD Management, LLC is the manager of SHD II. The reporting person is the Chief Executive Officer of SHD Management, LLC and may be deemed to beneficially own the shares of common stock held by SHD II.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney